Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
, functional genomics, protein engineering, and targeted protein degradation. Project background High-throughput perturbation technologies rely on perturbing DNA or RNA to infer the function of proteins. Methods
-
to establish an innovative platform for peptide drug discovery. Project background Peptides are privileged modalities for the development of new therapeutic avenues. To address unexploited targets and offer
-
management Excellent command of German and ideally also English; able to write clear, engaging, and well-targeted content for a broad audience, including platform texts and public-facing communication
-
to engineer human cells and develop advanced gene and cell therapies targeting cancer, as well as metabolic, neurodegenerative, autoimmune and infectious diseases. For more information, please consult our
-
an associate professor (or above) under the age of 50 when applying for senior scholar programs - Have attained the level of Chinese proficiency (HSK) required by the target program . Please refer to
-
. The successful candidate will be part of an ongoing effort to enhance immune system function - either by targeting PMN-MDSCs or developing CAR T cells and bispecific engagers for prostate cancer therapy
-
the selection of further reactions to run, and their application to targets of medicinal interest. Job description As a PhD student in our growing team, you will develop machine learning methods to predict
-
specific protocols and rules. We employ sophisticated data analytics and targeted modelling to uncover the fundamental mechanisms driving these emergent properties. Core Research Areas Blockchain Analytics
-
data analytics and targeted modelling to uncover the fundamental mechanisms driving these emergent properties. Core Research Areas Blockchain Analytics Cryptoeconomics and Incentive Design Consensus
-
the therapeutic area network Establish an intellectual home for the Dementia network of pRED, aimed at ensuring the successful delivery of the portfolio in the therapeutic area from target assessment to completion